Table 4 Multivariate analysis of patients’ 5-year overall survival
Variable | P-value | Relative risk (95Â % CI) |
|---|---|---|
Sex (male/female) | 0.193 | 1.944 (0.737–6.710) |
Lymphatic invasion (ly1–3/ly0) | 0.222 | 1.628 (0.756–3.925) |
Tumor depth (pT3–4/pT1–2) | 0.26 | 1.911 (0.644–7.047) |
Lymph node metastasis (pN1/pN0) | 0.025a | 3.852 (1.169–16.335) |
Pathological stage (pStage III–IV/I–II) | 0.814 | 0.856 (0.215–2.898) |
c-Met expression (high/low) | 0.033a | 2.237 (1.066–5.190) |
HGF expression (high/low) | 0.821 | 1.075 (0.572–2.012) |